Oragenics strikes deal with Intrexon

Oragenics Inc. received a $3.9 million capital boost from Intrexon Corp., as the two companies agreed to work together to develop and commercialize genetically modified probiotics...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.